Nalwalk JW - Search Results

1

Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studies.

Tedford CE, Yates SL, Pawlowski GP, Nalwalk JW, Hough LB, Khan MA, Phillips JG, Durant GJ, Frederickson RC. Tedford CE, et al. Among authors: nalwalk jw. J Pharmacol Exp Ther. 1995 Nov;275(2):598-604. J Pharmacol Exp Ther. 1995. PMID: 7473144

2

Inhibition of morphine antinociception by centrally administered histamine H2 receptor antagonists.

Hough LB, Nalwalk JW. Hough LB, et al. Among authors: nalwalk jw. Eur J Pharmacol. 1992 Apr 29;215(1):69-74. doi: 10.1016/0014-2999(92)90610-g. Eur J Pharmacol. 1992. PMID: 1355443

3

Characterization of the antinociceptive properties of cimetidine and a structural analog.

Li BY, Nalwalk JW, Barker LA, Cumming P, Parsons ME, Hough LB. Li BY, et al. Among authors: nalwalk jw. J Pharmacol Exp Ther. 1996 Feb;276(2):500-8. J Pharmacol Exp Ther. 1996. PMID: 8632315

4

Novel qualitative structure-activity relationships for the antinociceptive actions of H2 antagonists, H3 antagonists and derivatives.

Hough LB, Nalwalk JW, Li BY, Leurs R, Menge WM, Timmerman H, Carlile ME, Cioffi C, Wentland M. Hough LB, et al. Among authors: nalwalk jw. J Pharmacol Exp Ther. 1997 Dec;283(3):1534-43. J Pharmacol Exp Ther. 1997. PMID: 9400031

5

Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.

Hough LB, Nalwalk JW, Stadel R, Timmerman H, Leurs R, Paria BC, Wang X, Dey SK. Hough LB, et al. Among authors: nalwalk jw. J Pharmacol Exp Ther. 2002 Oct;303(1):314-22. doi: 10.1124/jpet.102.036251. J Pharmacol Exp Ther. 2002. PMID: 12235266

6

Activation of spinal histamine H3 receptors inhibits mechanical nociception.

Cannon KE, Nalwalk JW, Stadel R, Ge P, Lawson D, Silos-Santiago I, Hough LB. Cannon KE, et al. Among authors: nalwalk jw. Eur J Pharmacol. 2003 Jun 6;470(3):139-47. doi: 10.1016/s0014-2999(03)01737-0. Eur J Pharmacol. 2003. PMID: 12798951

7

Modulation of morphine antinociception by antagonism of H2 receptors in the periaqueductal gray.

Hough LB, Nalwalk JW. Hough LB, et al. Among authors: nalwalk jw. Brain Res. 1992 Aug 14;588(1):58-66. doi: 10.1016/0006-8993(92)91344-e. Brain Res. 1992. PMID: 1356588

8

Importance of histamine H2 receptors in restraint-morphine interactions.

Nalwalk JW, Hough LB. Nalwalk JW, et al. Life Sci. 1995;57(13):PL153-8. doi: 10.1016/0024-3205(95)02078-w. Life Sci. 1995. PMID: 7674814

9

Role of stress in histamine-morphine interactions.

Hough LB, Nalwalk JW. Hough LB, et al. Among authors: nalwalk jw. Inflamm Res. 1995 Apr;44 Suppl 1:S40-1. doi: 10.1007/BF01674386. Inflamm Res. 1995. PMID: 8520992 No abstract available.

10

Effects of naltrexone and histamine antagonists on the antinociceptive activity of the cimetidine analog SKF92374 in rats.

Li BY, Nalwalk JW, Hough LB. Li BY, et al. Among authors: nalwalk jw. Brain Res. 1997 Feb 14;748(1-2):168-74. doi: 10.1016/s0006-8993(96)01288-7. Brain Res. 1997. PMID: 9067458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page